Baker Avenue Asset Management LP acquired a new position in shares of Centene Corporation (NYSE:CNC – Free Report) during the fourth quarter, Holdings Channel reports. The institutional investor acquired 9,121 shares of the company’s stock, valued at approximately $375,000.
A number of other hedge funds and other institutional investors have also made changes to their positions in CNC. Prime Capital Investment Advisors LLC lifted its position in shares of Centene by 5.7% during the 4th quarter. Prime Capital Investment Advisors LLC now owns 5,975 shares of the company’s stock valued at $246,000 after buying an additional 324 shares in the last quarter. Burney Co. lifted its position in shares of Centene by 3.8% during the 4th quarter. Burney Co. now owns 9,053 shares of the company’s stock valued at $373,000 after buying an additional 331 shares in the last quarter. Sapient Capital LLC lifted its position in shares of Centene by 4.0% during the 4th quarter. Sapient Capital LLC now owns 9,442 shares of the company’s stock valued at $389,000 after buying an additional 359 shares in the last quarter. Snowden Capital Advisors LLC lifted its position in shares of Centene by 8.0% during the 2nd quarter. Snowden Capital Advisors LLC now owns 5,073 shares of the company’s stock valued at $275,000 after buying an additional 374 shares in the last quarter. Finally, MassMutual Private Wealth & Trust FSB lifted its position in shares of Centene by 15.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 2,785 shares of the company’s stock valued at $115,000 after buying an additional 379 shares in the last quarter. Institutional investors and hedge funds own 93.63% of the company’s stock.
Centene Trading Up 1.4%
Shares of CNC stock opened at $59.72 on Friday. The stock’s fifty day moving average is $45.44 and its two-hundred day moving average is $42.41. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.12 and a current ratio of 1.12. The firm has a market capitalization of $29.49 billion, a P/E ratio of -4.54, a PEG ratio of 0.47 and a beta of 1.06. Centene Corporation has a fifty-two week low of $25.08 and a fifty-two week high of $60.76.
Wall Street Analysts Forecast Growth
A number of research analysts have recently issued reports on CNC shares. Argus upgraded Centene to a “hold” rating in a research report on Monday, February 9th. Cantor Fitzgerald upgraded Centene from a “neutral” rating to an “overweight” rating and increased their target price for the company from $41.00 to $60.00 in a research report on Tuesday, April 28th. Deutsche Bank Aktiengesellschaft upgraded Centene from a “hold” rating to a “buy” rating and increased their target price for the company from $53.00 to $80.00 in a research report on Wednesday, May 20th. Mizuho set a $58.00 target price on Centene and gave the company a “neutral” rating in a research report on Wednesday, May 20th. Finally, Jefferies Financial Group increased their target price on Centene from $39.00 to $48.00 and gave the company a “hold” rating in a research report on Wednesday, April 29th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, nine have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $58.18.
Get Our Latest Research Report on Centene
Centene Profile
Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.
Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.
Recommended Stories
- Five stocks we like better than Centene
- Costco’s Strong Quarter Still Leaves Investors With a Valuation Problem
- These 3 Software Stocks Are Buying Back Shares Hand Over Fist
- Gap Inc. Cuts Sales Outlook After Q1 Miss, Shares Drop 17%
- MongoDB’s AI Advantage Is Starting to Show Up in Results
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corporation (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
